David M. Peereboom

Cleveland Clinic Lerner College of Medicine

Also affiliated with University Hospitals Seidman Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma”.

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00996

N/A

2.3DataRank · unranked

159 citations

David A. Reardon, Ajay Abad, William T. Curry, Eric T. Wong, Sheila Figel +15 more

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Blood Advances(2020)10.1182/bloodadvances.2020001804

N/A

0.920DataRank · unranked

30 citations

Joanna Roopkumar, Mäneka Puligandla, Benjamin L. Schlechter, Anish V. Sharda, David M. Peereboom +6 more

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression

Frontiers in Immunology(2020)10.3389/fimmu.2020.01191

N/A

0.761DataRank · unranked

159 citations

Defne Bayık, Balint Otvos, Anja Rabljenovic, Lin Leng, Jia-Shiun Leu +12 more

A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101630

N/A

0.327DataRank · unranked

5 citations

Ahmad Ozair, Michelle A. Rudek, Xiaobu Ye, Matthias Holdhoff, Frank S. Lieberman +11 more

Intratumoral drug distribution of adavosertib in patients with glioblastoma: Interim results of phase I study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2568

N/A

0.292DataRank · unranked

6 citations

Brian M. Alexander, Nathalie Y.R. Agar, Manmeet S. Ahluwalia, Arati Desai, Jörg Dietrich +14 more

A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma

Neurosurgery(2020)10.1093/neuros/nyaa412

N/A

0DataRank · unranked

33 citations

Xiaobu Ye, Tom Mikkelsen, Glenn J. Lesser, Frank S. Lieberman, H. Ian Robins +4 more

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.07.019

N/A

0DataRank · unranked

18 citations

Kathryn Winter, Paul W. Sperduto, Jennifer F. De Los Santos, David M. Peereboom, Tomi Ogunleye +17 more

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

Neuro-Oncology(2020)10.1093/neuonc/noaa062

N/A

0DataRank · unranked

46 citations

Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu +18 more

Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM

Cancer Immunology Immunotherapy(2025)10.1007/s00262-025-04193-y

N/A

0DataRank · unranked

2 citations

Sheila Figel, Jingxin Qiu, Manmeet S. Ahluwalia, David Reardon, Ajay Abad +8 more